Anti-rheumatic drugs
Identifieur interne : 003779 ( Main/Exploration ); précédent : 003778; suivant : 003780Anti-rheumatic drugs
Auteurs : T. R. Littler [Royaume-Uni]Source :
- Pharmacology and Therapeutics [ 0163-7258 ] ; 1981.
English descriptors
- Teeft :
- Abnormality, Adjuvant arthritis, Adverse reactions, Ankylosing spondylitis, Ansell, Arthritis, Arthritis rheum, Arthropathy, Aurothiomalate, Azathioprine, Beneficial effect, Benoxaprofen, Bone marrow, Cessation, Chloroquine, Chrysotherapy, Clinical improvement, Clinical response, Clinical trials, Clinician, Clozic, Corticosteroid, Corticosteroid drugs, Corticosteroid preparations, Corticosteroid therapy, Corticotrophin, Crockson, Cutaneous, Cutaneous vasculitis, Cyclophosphamide, Dapsone, Dermatitis herpetiformis, Disease activity, Dos, Dosage, Drug treatment, Early cases, Early stages, Erythematosus, Erythrocyte sedimentation rate, Eular, Eular publishers, Excellent reviews, Favorable results, Fenclofenac, General health, Gold salts, Gold therapy, Guide lines, Hemoglobin level, Huskisson, Hydroxychloroquine, Immune, Immune system, Intramuscular, Knee joints, Lancet, Levamisole, Littler, Lupus, Lupus erythematosus, Maintenance dose, Malignant disease, Many years, Mcconkey, Mowat, Mucosal surfaces, Multicentre, Myasthenia gravis, Palindromic arthritis, Patient compliance, Penicillamine, Penicillamine therapy, Polyarthritis, Prednisolone, Prostaglandin, Prostaglandin synthesis, Psoriatic arthropathy, Radiographic progression, Rash, Remission, Rheum, Rheumatic, Rheumatic disease, Rheumatic diseases, Rheumatic polyarthritis, Rheumatoid, Rheumatoid arthritis, Rheumatoid disease, Rheumatoid factor, Rheumatoid factor titres, Rheumatol, Rheumatological practice, Same reason, Saunders, Side effects, Significant reduction, Sodium aurothiomalate, Steroid, Steroid therapy, Strength tablets, Subjective improvement, Such cases, Such circumstances, Suppl, Systemic lupus erythematosus, Therapy, Ulceration, Whilst.
Url:
DOI: 10.1016/0163-7258(81)90015-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000120
- to stream Istex, to step Curation: 000120
- to stream Istex, to step Checkpoint: 002537
- to stream Main, to step Merge: 003858
- to stream Main, to step Curation: 003779
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Anti-rheumatic drugs</title>
<author><name sortKey="Littler, T R" sort="Littler, T R" uniqKey="Littler T" first="T. R." last="Littler">T. R. Littler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2EFAD243EEB9B9184B35ED00A9D693C0BB876C62</idno>
<date when="1981" year="1981">1981</date>
<idno type="doi">10.1016/0163-7258(81)90015-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-ZGP17PJP-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000120</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000120</idno>
<idno type="wicri:Area/Istex/Curation">000120</idno>
<idno type="wicri:Area/Istex/Checkpoint">002537</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002537</idno>
<idno type="wicri:doubleKey">0163-7258:1981:Littler T:anti:rheumatic:drugs</idno>
<idno type="wicri:Area/Main/Merge">003858</idno>
<idno type="wicri:Area/Main/Curation">003779</idno>
<idno type="wicri:Area/Main/Exploration">003779</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Anti-rheumatic drugs</title>
<author><name sortKey="Littler, T R" sort="Littler, T R" uniqKey="Littler T" first="T. R." last="Littler">T. R. Littler</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University of Liverpool and Leasowe Hospital Rheumatology Unit, Liverpool L69 3BX, Merseyside</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Pharmacology and Therapeutics</title>
<title level="j" type="abbrev">JPT</title>
<idno type="ISSN">0163-7258</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1981">1981</date>
<biblScope unit="volume">15</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="45">45</biblScope>
<biblScope unit="page" to="68">68</biblScope>
</imprint>
<idno type="ISSN">0163-7258</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0163-7258</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term>
<term>Adjuvant arthritis</term>
<term>Adverse reactions</term>
<term>Ankylosing spondylitis</term>
<term>Ansell</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Arthropathy</term>
<term>Aurothiomalate</term>
<term>Azathioprine</term>
<term>Beneficial effect</term>
<term>Benoxaprofen</term>
<term>Bone marrow</term>
<term>Cessation</term>
<term>Chloroquine</term>
<term>Chrysotherapy</term>
<term>Clinical improvement</term>
<term>Clinical response</term>
<term>Clinical trials</term>
<term>Clinician</term>
<term>Clozic</term>
<term>Corticosteroid</term>
<term>Corticosteroid drugs</term>
<term>Corticosteroid preparations</term>
<term>Corticosteroid therapy</term>
<term>Corticotrophin</term>
<term>Crockson</term>
<term>Cutaneous</term>
<term>Cutaneous vasculitis</term>
<term>Cyclophosphamide</term>
<term>Dapsone</term>
<term>Dermatitis herpetiformis</term>
<term>Disease activity</term>
<term>Dos</term>
<term>Dosage</term>
<term>Drug treatment</term>
<term>Early cases</term>
<term>Early stages</term>
<term>Erythematosus</term>
<term>Erythrocyte sedimentation rate</term>
<term>Eular</term>
<term>Eular publishers</term>
<term>Excellent reviews</term>
<term>Favorable results</term>
<term>Fenclofenac</term>
<term>General health</term>
<term>Gold salts</term>
<term>Gold therapy</term>
<term>Guide lines</term>
<term>Hemoglobin level</term>
<term>Huskisson</term>
<term>Hydroxychloroquine</term>
<term>Immune</term>
<term>Immune system</term>
<term>Intramuscular</term>
<term>Knee joints</term>
<term>Lancet</term>
<term>Levamisole</term>
<term>Littler</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Maintenance dose</term>
<term>Malignant disease</term>
<term>Many years</term>
<term>Mcconkey</term>
<term>Mowat</term>
<term>Mucosal surfaces</term>
<term>Multicentre</term>
<term>Myasthenia gravis</term>
<term>Palindromic arthritis</term>
<term>Patient compliance</term>
<term>Penicillamine</term>
<term>Penicillamine therapy</term>
<term>Polyarthritis</term>
<term>Prednisolone</term>
<term>Prostaglandin</term>
<term>Prostaglandin synthesis</term>
<term>Psoriatic arthropathy</term>
<term>Radiographic progression</term>
<term>Rash</term>
<term>Remission</term>
<term>Rheum</term>
<term>Rheumatic</term>
<term>Rheumatic disease</term>
<term>Rheumatic diseases</term>
<term>Rheumatic polyarthritis</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid disease</term>
<term>Rheumatoid factor</term>
<term>Rheumatoid factor titres</term>
<term>Rheumatol</term>
<term>Rheumatological practice</term>
<term>Same reason</term>
<term>Saunders</term>
<term>Side effects</term>
<term>Significant reduction</term>
<term>Sodium aurothiomalate</term>
<term>Steroid</term>
<term>Steroid therapy</term>
<term>Strength tablets</term>
<term>Subjective improvement</term>
<term>Such cases</term>
<term>Such circumstances</term>
<term>Suppl</term>
<term>Systemic lupus erythematosus</term>
<term>Therapy</term>
<term>Ulceration</term>
<term>Whilst</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
</region>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Littler, T R" sort="Littler, T R" uniqKey="Littler T" first="T. R." last="Littler">T. R. Littler</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003779 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003779 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:2EFAD243EEB9B9184B35ED00A9D693C0BB876C62 |texte= Anti-rheumatic drugs }}
This area was generated with Dilib version V0.6.33. |